Open Journal Systems

Advances in Research and Clinical Application of Tumor Markers in Esophageal Cancer

Man Li (Liaoning University of Traditional Chinese Medicine, Shenyang, China)


Esophageal cancer is a common malignant tumor of the upper gastrointestinal tract. Early symptoms of the disease are inconspicuous and the disease is often diagnosed at a later stage, leading to higher morbidity and mortality. Esophageal cancer morbidity and mortality in both genders ranks among the top 10 most common cancers. Early detection and early treatment are effective means to reduce the incidence and mortality of esophageal cancer. Tumor markers play an important role in early diagnosis, treatment monitoring and prognosis evaluation of esophageal cancer. This paper reviews the clinical application of tumor markers related to esophageal cancer and the exploration and application progress of new tumor markers for esophageal cancer.


Tumor markers; Esophageal cancer; Diagnosis; ESCC

Full Text:



Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[ J]. CA Cancer J Clin, 2018, 68(6): 394-424.

Zheng RS, Sun KX, Zhang W W, et al. Epidemiology of malignant tumors in China in 2015 [J]. Chinese Journal of Oncology, 2019, 1(41): 19-28.

LI Daojuan, LIANG Di, JIN Jing, et al. J Cancer, 2018, 31(01): 62-68. (in Chinese with English abstract)

Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates[ J]. Cancer, 2010, 116(3): 544-573.

CAO H, JIANG H. Detection value of serum squamous cell carcinoma associated antigen, carcinoembryonic antigen, neuron-specific enolase and cytokeratin 19 fragment antigen in diagnosis of esophageal carcinoma [J]. China Medical Review, 2013, 10(14): 96-97, 100.

Wang YL, Zhao YZ, Xu GC, et al. The level of serum tumor markers and their combined detection significance for the diagnosis of esophageal cancer [J]. Chongqing Medical Journal, 2016, 45(03): 419-420, 430.

Jing JX, Wang Y, Xu XQ, et al. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer[ J]. Asian Pac J Cancer Prev, 2014, 15(23): 10267-10272.

Ling H, Chen X Y, Chen Z Z. Analysis of the value of combined detection of five tumor markers in the assisted diagnosis of esophageal cancer [J]. China Practical Medical Journal, 2019, 46(3): 100-101.

Zhang Airong. The value of multiple tumor markers combined detection in the diagnosis of esophageal cancer [J]. In the

Chinese Journal of Primary Medicine, 2011(4):549-550.

Zhang HongLei, Gao ChunFang, Hu Wenhua. Research progress of tumor markers of esophageal cancer [J]. In the

Chinese Journal of Clinical Oncology, 2007, (4): 367-369.

Liu T, Guo J J, Zhou H F, et al. The relationship between recurrence and metastasis of esophageal squamous cell carcinoma

[J]. Chinese Journal of Experimental Surg, 2017, 26 (1) : 1-7.

(2) : 311-313.

Wai C, Xu J M, Wang Y L. The role of exosomes in the diagnosis of digestive system tumors

[J]. Chinese Journal of Digestion, 2016, (35):35-42. (in Chinese)

Liu Ran, Liu Juan, Shi Yajun. Relationship between exosomal miR-21 and esophageal cancer

Research [C]. Chinese Society of Toxicology 4th Young and Middle-aged Scholars Science and Technology Forum, 2014.

Hu H, Li X Y, Yang B, et al. Expression of macrophage colony-stimulating factor in gastric cancer and its effect on tumor invasion and metastasis [J]. International Journal of Digestive Diseases,

, 38 (5) : 32-35, 48.

Ł ukaszewicz - Zajac M, Mroczko B, Koz ł Owski M, et al. Clinical

significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers[ J]. Clin Chem Lab Med, 2010, 48(10):1467-1473.

Shao Y,Geng Y,Gu W, et al. Prognostic significance of microRNA-375 downregulation in solid tumors:a meta-analysis[ J].Dis Markers, 2014, 2014:1-10.

Lee E, Lee BB, Ko E, et al. Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma[J]. Cancer, 2013119 (9) : 1752-1760.

DasM,SharmaSK,SekhonGS,etal.PromotermethylationofMGMT gene in serum of patients with esophageal squamous cell carcinoma inNorth East India[ J]. Asian Pac J Cancer Prev,2014, 15(22):9955-9960.

Jin Z, Zhao Z, Chen Y, et al. Endoglin promoter hypermethylation identifies a field defect in human primary esophageal[ J]. Cancer, 2013,


Hou X, Wen J, Ren Z, et al. Non-coding RNAs: new biomarkers

and therapeutic targets for esophageal cancer[J]. Oncotarget,2017,


Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and

therapeutic gold mine[ J]. Mod Pathol,2012, 26:155–165.

Yang M, Liu R, Sheng J, et al. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma[ J]. Oncol Rep, 2013, 29(1): 169-

Li J, Ju J, Ni B, et al. The emerging role of miR-506 in cancer[J].

Oncotarget,2016, 7:62778-62788.

Sugihara H, Ishimoto T, Miyake K, et al. Noncoding RNA expression

aberration is associated with cancer progression and is a potential biomarker in esophageal squamous cell carcinoma[J]. Int J Mol Sci,2015, 16:27824-27834.

WanJ,WuW,CheY,etal.InsightsintothepotentialuseofmicroRNAs as a novel class of biomarkers in esophageal cancer[ J]. Dis Esophagus, 2016, 29(5): 412-420.

Tong K, Xie W, Wang CY, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma[ J]. Molec Cancer, 2015, 14(1):1- 13.

Niu Chaoxia. The relationship between Survivin and early diagnosis, treatment and prognosis of esophageal carcinoma [J]. Journal of the Chinese Medical College, 2016, 33(03): 246-249.

Zhang Deqing, Meng Guangyuan, Li Yijiin et al. Survivin expression in esophageal cancer tissue and clinical significance [J]. Journal of Taishan Medical University, 2006, 27(2):113-116.

Ma S, Zhao X. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation[ J]. Oncol Rep, 2014, 32(4): 1631-1637.

Xie M, Zhong HL, Lei GW, et al. Expression of KPNA2 in colorectal cancer and its clinical significance[J]. Journal of Diagnostic Pathology, 2019, 26(01):39-42.

Ma HB, Yang GY. Expression and significance of high mobility protein B1 and vascular endothelial growth factor in human esophageal squamous cell carcinoma [J]. China Practical Medical Journal, 2010, 37(8): 31-32, 34.

Chen Chuangui, Cui Lin, Tang Peng, et al. Clinical significance of high mobility group of egg white B1 in patients with esophageal squamous cell carcinoma [J]. Chinese Journal of Gastrointestinal Surgery,2013,16(9):838-841.

Xie Z, Chen G, Zhang X, et al. Salivary microRNAs as promising biomarkers for detection of esophageal cancer[J]. PLoS One, 2013, 8(4): e57502.

Sedighi M, Aledavood SA, Abbaszadegan M, et al. Matrix metalloproteinase-13-A potential biomarker for detection and prognostic assessment of patients with esophageal squamous cell carcinoma[ J]. Asian Pac J Cancer Prev, 2016, 17(6): 2781-2785.

Qi L, Li LX, Song LN, et al. Evaluation of serum DR-70(FDP) in the diagnosis of malignant tumors[J]. Chinese Journal of Experimental Diagnostics, 2015(11):1883-1885.



  • There are currently no refbacks.

Copyright (c) 2020 Man Li

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.